NIDA Hosts Meeting to Review Drug Research Funding
Published Date: 8/15/2025
Notice
Summary
The National Institute on Drug Abuse is holding a hybrid meeting on September 9, 2025, to review grant applications and discuss important drug research topics. Anyone interested can join in person or online, but space is limited, and some parts of the meeting will be private to protect sensitive info. This meeting affects researchers seeking funding and helps guide future drug abuse studies.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 0 costs, 2 mixed.
NIDA Will Review Grant Applications
On September 9, 2025, the National Advisory Council on Drug Abuse will meet and will review and evaluate grant applications during a closed session from 10:30 a.m. to 11:45 a.m. The closed session is to protect confidential trade secrets, patentable material, and personal information of applicants.
Public Can Attend Hybrid Meeting
The meeting on September 9, 2025 has an open hybrid session from 1:00 p.m. to 5:00 p.m. You can attend in person or virtually by registering at the link provided, but attendance is limited to space available.
Accessibility and Security Requirements
If you need special assistance such as sign language interpretation to attend the meeting, you must notify Dr. Gillian Acca by email at least five days before the meeting. In-person attendees will be subject to NIH campus security procedures, including showing one form of identification and vehicle inspection.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in